StonvexLoading…
StonvexStonvexStonvexCore line items from CLVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $585.50M | $2.46B | $1.84B | $1.22B |
Operating Income | $30.20M | $71.50M | $30.10M | $-13.90M |
Net Income | $-40.20M | $-201.10M | $-204.20M | $-72.00M |
EPS (Diluted) | $-0.06 | $-0.30 | $-0.30 | $-0.26 |
Total Assets | $10.93B | $11.07B | $11.23B | $11.42B |
Total Liabilities | $6.14B | $6.23B | $6.32B | $6.43B |
Cash & Equivalents | $242.20M | $329.20M | $318.70M | $362.60M |
Free Cash Flow OCF − CapEx | $78.90M | $365.30M | $276.10M | $160.60M |
Shares Outstanding | 639.20M | 640.70M | 661.40M | 672.20M |